State Of Wisconsin Investment Board Arrowhead Pharmaceuticals, Inc. Transaction History

State Of Wisconsin Investment Board

$36.9 Billion
Q4 2024

A detailed history of State Of Wisconsin Investment Board transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, State Of Wisconsin Investment Board holds 66,051 shares of ARWR stock, worth $1.01 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

66,051

Previous 67,768 2.53%

Holding current value

$1.01 Million

Previous $1.31 Million 5.34%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$17.7 - $26.34 $30,390 - $45,225	-1,717 Reduced 2.53%	66,051 $1.24 Million
Q3 2024 Nov 14, 2024	SELL	$19.36 - $29.54 $74,768 - $114,083	-3,862 Reduced 5.39%	67,768 $1.31 Million
Q2 2024 Aug 14, 2024	SELL	$21.87 - $28.24 $87,392 - $112,847	-3,996 Reduced 5.28%	71,630 $1.86 Million
Q1 2024 May 14, 2024	SELL	$27.21 - $39.48 $214,251 - $310,865	-7,874 Reduced 9.43%	75,626 $2.16 Million
Q4 2023 Feb 12, 2024	SELL	$21.2 - $31.03 $39,622 - $57,995	-1,869 Reduced 2.19%	83,500 $2.56 Million
Q3 2023 Nov 14, 2023	SELL	$26.2 - $36.08 $76,530 - $105,389	-2,921 Reduced 3.31%	85,369 $2.29 Million
Q2 2023 Aug 14, 2023	SELL	$25.16 - $41.38 $119,610 - $196,720	-4,754 Reduced 5.11%	88,290 $3.15 Million
Q1 2023 May 15, 2023	SELL	$23.68 - $38.51 $184,538 - $300,108	-7,793 Reduced 7.73%	93,044 $2.36 Million
Q4 2022 Feb 14, 2023	SELL	$28.0 - $40.56 $47,292 - $68,505	-1,689 Reduced 1.65%	100,837 $4.09 Million
Q3 2022 Nov 14, 2022	SELL	$29.63 - $48.31 $156,890 - $255,801	-5,295 Reduced 4.91%	102,526 $3.39 Million
Q2 2022 Aug 15, 2022	SELL	$27.79 - $50.61 $777,536 - $1.42 Million	-27,979 Reduced 20.6%	107,821 $3.8 Million
Q4 2021 Feb 11, 2022	SELL	$58.09 - $82.51 $23,236 - $33,004	-400 Reduced 0.29%	135,800 $9 Million
Q3 2021 Nov 12, 2021	BUY	$58.38 - $84.96 $81,732 - $118,943	1,400 Added 1.04%	136,200 $8.5 Million
Q2 2021 Aug 12, 2021	SELL	$62.15 - $90.32 $186,450 - $270,960	-3,000 Reduced 2.18%	134,800 $11.2 Million
Q1 2021 May 17, 2021	SELL	$61.35 - $90.47 $177,915 - $262,363	-2,900 Reduced 2.06%	137,800 $9.14 Million
Q4 2020 Feb 03, 2021	SELL	$43.82 - $85.37 $889,546 - $1.73 Million	-20,300 Reduced 12.61%	140,700 $10.8 Million
Q2 2020 Aug 12, 2020	BUY	$26.12 - $43.27 $167,168 - $276,928	6,400 Added 4.14%	161,000 $6.95 Million
Q1 2020 May 06, 2020	BUY	$20.56 - $63.12 $308,400 - $946,800	15,000 Added 10.74%	154,600 $4.45 Million
Q3 2019 Nov 12, 2019	BUY	$26.26 - $34.86 $91,910 - $122,010	3,500 Added 2.57%	139,600 $3.93 Million
Q2 2019 Aug 14, 2019	BUY	$17.43 - $28.82 $244,020 - $403,480	14,000 Added 11.47%	136,100 $3.61 Million
Q1 2019 May 13, 2019	BUY	$12.05 - $20.18 $386,805 - $647,778	32,100 Added 35.67%	122,100 $2.24 Million
Q4 2018 Feb 11, 2019	BUY	$10.74 - $19.7 $13,962 - $25,610	1,300 Added 1.47%	90,000 $1.12 Million
Q2 2018 Aug 03, 2018	BUY	$6.37 - $14.02 $565,019 - $1.24 Million	88,700 New	88,700 $1.21 Million

Others Institutions Holding ARWR

# of Institutions

305

Shares Held

95.9M

Call Options Held

523K

Put Options Held

493K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $1.63B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.

Account

State Of Wisconsin Investment Board Arrowhead Pharmaceuticals, Inc. Transaction History